Jeff is a pharmaceutical industry professional with over 35 years of drug development experience leading Regulatory development efforts ranging from early-stage compounds to post-approval support across numerous product platforms and therapeutic areas covering both North America and Europe. Jeff has been a Regulatory Affairs consultant for the past 16 years where he has filed multiple INDs and lead a number of compounds into Phase 3. Prior to becoming an independent consultant, Jeff worked at Cell Therapeutics as Vice President of Regulatory Affairs and 10 years at Amgen where he was involved in multiple BLA/NDA filings and approvals including anakinra, cinacalcet, and interferon alfacon-1. He has a B.S. in Microbiology from Oregon State University.
Sign up to view 0 direct reports
Get started